191 related articles for article (PubMed ID: 17289817)
1. Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
Hossain MS; Roback JD; Pollack BP; Jaye DL; Langston A; Waller EK
Blood; 2007 May; 109(10):4548-56. PubMed ID: 17289817
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation.
Roback JD; Hossain MS; Lezhava L; Gorechlad JW; Alexander SA; Jaye DL; Mittelstaedt S; Talib S; Hearst JE; Hillyer CD; Waller EK
J Immunol; 2003 Dec; 171(11):6023-31. PubMed ID: 14634114
[TBL] [Abstract][Full Text] [Related]
3. Concurrent MCMV infection augments donor antihost-specific activity and alters clinical outcome following experimental allogenic bone marrow transplantation.
Jones M; Cray C; Levy RB
Transplantation; 1996 Mar; 61(6):856-61. PubMed ID: 8623149
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients.
Li JM; Hossain MS; Southerland L; Waller EK
Blood; 2013 Mar; 121(12):2347-51. PubMed ID: 23325838
[TBL] [Abstract][Full Text] [Related]
5. Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.
Wu Y; Fu J; Wang H; Yu XZ
Front Immunol; 2021; 12():778996. PubMed ID: 34950143
[TBL] [Abstract][Full Text] [Related]
6. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
[TBL] [Abstract][Full Text] [Related]
7. Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation.
Alpdogan SO; Lu SX; Patel N; McGoldrick S; Suh D; Budak-Alpdogan T; Smith OM; Grubin J; King C; Goldberg GL; Hubbard VM; Kochman AA; van den Brink MR
Blood; 2008 Dec; 112(12):4755-64. PubMed ID: 18815289
[TBL] [Abstract][Full Text] [Related]
8. The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation.
Nguyen VH; Shashidhar S; Chang DS; Ho L; Kambham N; Bachmann M; Brown JM; Negrin RS
Blood; 2008 Jan; 111(2):945-53. PubMed ID: 17916743
[TBL] [Abstract][Full Text] [Related]
9. BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation.
Jia W; Poe JC; Su H; Anand S; Matsushima GK; Rathmell JC; Maillard I; Radojcic V; Imai K; Reyes NJ; Cardona DM; Li Z; Suthers AN; Curry-Chisolm IM; DiCioccio RA; Saban DR; Chen BJ; Chao NJ; Sarantopoulos S
Blood; 2021 May; 137(18):2544-2557. PubMed ID: 33534893
[TBL] [Abstract][Full Text] [Related]
10. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Tedder TF; Fujimoto M
Blood; 2013 Apr; 121(16):3274-83. PubMed ID: 23422748
[TBL] [Abstract][Full Text] [Related]
11. Absence of vasoactive intestinal peptide expression in hematopoietic cells enhances Th1 polarization and antiviral immunity in mice.
Li JM; Southerland L; Hossain MS; Giver CR; Wang Y; Darlak K; Harris W; Waschek J; Waller EK
J Immunol; 2011 Jul; 187(2):1057-65. PubMed ID: 21677142
[TBL] [Abstract][Full Text] [Related]
12. Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.
Hossain MS; Jaye DL; Pollack BP; Farris AB; Tselanyane ML; David E; Roback JD; Gewirtz AT; Waller EK
J Immunol; 2011 Nov; 187(10):5130-40. PubMed ID: 22013117
[TBL] [Abstract][Full Text] [Related]
13. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
[TBL] [Abstract][Full Text] [Related]
14. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
[TBL] [Abstract][Full Text] [Related]
15. Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity.
Müller AM; Shashidhar S; Küpper NJ; Kohrt HE; Florek M; Negrin RS; Brown JM; Shizuru JA
Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5820-5. PubMed ID: 22440752
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.
Anderson BE; McNiff JM; Jain D; Blazar BR; Shlomchik WD; Shlomchik MJ
Blood; 2005 Mar; 105(5):2227-34. PubMed ID: 15522961
[TBL] [Abstract][Full Text] [Related]
17. Corruption of dendritic cell antigen presentation during acute GVHD leads to regulatory T-cell failure and chronic GVHD.
Leveque-El Mouttie L; Koyama M; Le Texier L; Markey KA; Cheong M; Kuns RD; Lineburg KE; Teal BE; Alexander KA; Clouston AD; Blazar BR; Hill GR; MacDonald KP
Blood; 2016 Aug; 128(6):794-804. PubMed ID: 27338097
[TBL] [Abstract][Full Text] [Related]
18. Host and donor immune responses contribute to antiviral effects of amotosalen-treated donor lymphocytes following early posttransplant cytomegalovirus infection.
Hossain MS; Roback JD; Wang F; Waller EK
J Immunol; 2008 May; 180(10):6892-902. PubMed ID: 18453610
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation.
Alpdogan O; Eng JM; Muriglan SJ; Willis LM; Hubbard VM; Tjoe KH; Terwey TH; Kochman A; van den Brink MR
Blood; 2005 Jan; 105(2):865-73. PubMed ID: 15280205
[TBL] [Abstract][Full Text] [Related]
20. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
